Publications by authors named "Michael Ashby"

Nano-patterned magnetic materials have opened new venues for the investigation of strongly correlated phenomena including artificial spin-ice systems, geometric frustration, and magnetic monopoles, for technologically important applications such as reconfigurable ferromagnetism. With the advent of atomically thin 2D van der Waals (vdW) magnets, a pertinent question is whether such compounds could make their way into this realm where interactions can be tailored so that unconventional states of matter can be assessed. Here, it is shown that square islands of CrGeTe vdW ferromagnets distributed in a grid manifest antiferromagnetic correlations, essential to enable frustration resulting in an artificial spin-ice.

View Article and Find Full Text PDF

NMDA receptors (NMDARs) are ionotropic receptors crucial for brain information processing. Yet, evidence also supports an ion-flux-independent signaling mode mediating synaptic long-term depression (LTD) and spine shrinkage. Here, we identify AETA (Aη), an amyloid-β precursor protein (APP) cleavage product, as an NMDAR modulator with the unique dual regulatory capacity to impact both signaling modes.

View Article and Find Full Text PDF

Synapse loss is currently the best biological correlate of cognitive decline in Alzheimer's disease and other tauopathies. Synapses seem to be highly vulnerable to tau-mediated disruption in neurodegenerative tauopathies. However, it is unclear how and when this leads to alterations in function related to the progression of tauopathy and neurodegeneration.

View Article and Find Full Text PDF
Article Synopsis
  • A phase II study investigated the combined treatment of venetoclax and low-dose cytarabine (LDAC) for patients with acute myeloid leukemia (AML) experiencing first measurable residual disease (MRD) or oligoblastic relapse.
  • The study enrolled 48 adults, primarily older patients with a history of intensive chemotherapy, and assessed their response to the treatment over several cycles, with notable differences in side effects based on relapse type.
  • Results showed that the combination was not only well tolerated but also led to significant remission rates, with many patients achieving either MRD negativity or complete remission, indicating the treatment's potential effectiveness.
View Article and Find Full Text PDF

Arsenic trioxide is an essential component of therapy for acute promyelocytic leukaemia (APL) and is currently dosed on actual body weight with no upper limit. Arsenic-induced neurotoxicity is a well-recognised complication; however, there is uncertainty about its relationship to arsenic dose and obesity. We conducted a large multicentre retrospective study of 487 patients with APL treated with arsenic-based therapy across 23 sites in Australia from 2008 to 2023.

View Article and Find Full Text PDF

The goals of care (GOC) framework (2014) is an illness phase categorisation system that enables limitations of medical treatment (LOMT) to be documented and communicated within a healthcare system. It incorporates a clinical assessment of illness phase and GOC discussion on aims and LOMT for an episode of care. Together, this results in documentation of a GOC category that guides treatment escalation decisions during episodes of patient deterioration.

View Article and Find Full Text PDF

Lactoperoxidase (LPO, Fe in its resting state in the absence of substrates)-an enzyme secreted from human mammary, salivary, and other mucosal glands-catalyzes the oxidation of thiocyanate (SCN) by hydrogen peroxide (HO) to produce hypothiocyanite (OSCN), which functions as an antimicrobial agent. The accepted catalytic mechanism, called the halogen cycle, comprises a two-electron oxidation of LPO by HO to produce oxoiron(IV) radicals, followed by O-atom transfer to SCN. However, the mechanism does not explain biphasic kinetics and inhibition by HO at low concentration of reducing substrate, conditions that may be biologically relevant.

View Article and Find Full Text PDF